Status: current, Sufficiently defined by necessary conditions definition status. Date: 31-Jul 2018. Module: SNOMED CT core module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3686932014 | Product containing hydrochlorothiazide and propranolol in oral dosage form (medicinal product form) | en | Fully specified name | Inactive | Entire term case insensitive | SNOMED CT core module |
| 3686933016 | Hydrochlorothiazide and propranolol in oral dosage form | en | Synonym | Inactive | Entire term case insensitive | SNOMED CT core module |
| 3686934010 | Product containing hydrochlorothiazide and propranolol in oral dosage form | en | Synonym | Inactive | Entire term case insensitive | SNOMED CT core module |
| 3710297010 | Product containing hydrochlorothiazide and propranolol in oral dose form (medicinal product form) | en | Fully specified name | Active | Entire term case insensitive | SNOMED CT core module |
| 3710298017 | Hydrochlorothiazide- and propranolol-containing product in oral dose form | en | Synonym | Active | Entire term case insensitive | SNOMED CT core module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Product containing hydrochlorothiazide and propranolol in oral dose form (medicinal product form) | Has active ingredient | Propranolol | true | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing hydrochlorothiazide and propranolol in oral dose form (medicinal product form) | Is a | Product containing propranolol in oral dose form (medicinal product form) | true | Inferred relationship | Existential restriction modifier | ||
| Product containing hydrochlorothiazide and propranolol in oral dose form (medicinal product form) | Has manufactured dose form | Oral dose form | true | Inferred relationship | Existential restriction modifier | ||
| Product containing hydrochlorothiazide and propranolol in oral dose form (medicinal product form) | Has active ingredient | Hydrochlorothiazide | true | Inferred relationship | Existential restriction modifier | 2 | |
| Product containing hydrochlorothiazide and propranolol in oral dose form (medicinal product form) | Is a | Product containing hydrochlorothiazide and propranolol | true | Inferred relationship | Existential restriction modifier | ||
| Product containing hydrochlorothiazide and propranolol in oral dose form (medicinal product form) | Is a | Product containing hydrochlorothiazide in oral dose form (medicinal product form) | true | Inferred relationship | Existential restriction modifier | ||
| Product containing hydrochlorothiazide and propranolol in oral dose form (medicinal product form) | Plays role | Diuretic therapeutic role | true | Inferred relationship | Existential restriction modifier |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Product containing precisely hydrochlorothiazide 25 milligram and propranolol hydrochloride 80 milligram/1 each conventional release oral tablet | Is a | False | Product containing hydrochlorothiazide and propranolol in oral dose form (medicinal product form) | Inferred relationship | Existential restriction modifier | |
| Product containing precisely hydrochlorothiazide 25 milligram and propranolol hydrochloride 40 milligram/1 each conventional release oral tablet | Is a | False | Product containing hydrochlorothiazide and propranolol in oral dose form (medicinal product form) | Inferred relationship | Existential restriction modifier | |
| Product containing only hydrochlorothiazide and propranolol in oral dose form (medicinal product form) | Is a | True | Product containing hydrochlorothiazide and propranolol in oral dose form (medicinal product form) | Inferred relationship | Existential restriction modifier |
This concept is not in any reference sets
FHIR